Frequent, public drug users may be good candidates for overdose-treatment training

March 26, 2018, Johns Hopkins University Bloomberg School of Public Health

In response to America's opioid crisis, public health departments and community organizations across the country have started to train opioid users to reverse overdoses in other users with the opioid-blocker naloxone. The most frequent and public opioid users may be the best available candidates for naloxone training, according to a new study from scientists at Johns Hopkins Bloomberg School of Public Health.

The scientists interviewed 450 Baltimore drug users—the vast majority with histories of —and found that users who had witnessed more drug overdoses tended to be those who engaged in riskier drug use and used drugs in more places.

"A user can't administer naloxone to himself when he's overdosing, so from a standpoint we need to figure out which users are most likely to witness other users' overdoses and thus be in position to revive them," says senior author Carl A. Latkin, PhD, professor in the Bloomberg School's Department of Health, Behavior and Society. "Our results indicate that the likeliest witnesses are the heavier users who use in a wider range of settings."

The study, published in the journal Substance Abuse, comes as the crisis continues to worsen across the U.S. Emergency room visits for opioid overdoses surged by a third during 2016-2017, and the daily opioid-overdose death toll now averages 115, according to government statistics. Maryland, where statistics are dominated by Baltimore, is no exception to the trend. "Every time you look at the annual overdose fatality numbers for the state, they're higher," Latkin says.

Opioid drug overdoses can easily be fatal because these drugs' side effects include the suppression of brain cell activity that controls breathing. Naloxone, which can be administered by injection or nasal spray, powerfully blocks opioids' effects on brain cells, and thus can quickly restore normal breathing and consciousness in an overdose victim. But there is often only a brief window of opportunity for its effective use—particularly when the overdose involves one of the more potent opioids, such as fentanyl. "Since fentanyl is more potent and faster acting than heroin, you really need to ensure that naloxone is immediately available in the case of an overdose," Latkin says.

Maryland, like many other states, allows pharmacists to dispense naloxone without a prescription and sanctions naloxone training and distribution programs by health organizations. How to direct limited supplies of naloxone most effectively is an unanswered question, however.

The study stemmed from a larger HIV risk-reduction project in which hundreds of impoverished Baltimore were interviewed about their drug-use habits. Latkin and colleagues analyzed the interview data to find factors that would allow them to identify users who were most likely to witness overdoses—users who might therefore be good candidates for naloxone training.

The analysis covered 450 participants who had provided relevant information on their drug-use behaviors. Roughly 75 percent of these users reported that they had witnessed an overdose. About 12 percent had witnessed more than five. Not surprisingly, those who had witnessed more overdoses tended to be those whose behaviors indicated a deeper involvement in drug abuse. In the analysis, the behaviors that were most strongly associated with witnessing overdoses included injecting with heroin and/or "speedball" (cocaine plus heroin), snorting heroin, having an overdose history, using city needle-exchange programs and using drugs in a greater variety of places—such as public restrooms, "shooting galleries" and abandoned buildings.

"These results give us some clues about the individuals we should be training in the use of naloxone," Latkin says. "Drug users have consistently demonstrated their abilities to help others prevent HIV and treat overdose victims."

He emphasizes that this fact doesn't make the problem an easily soluble one. "Training users to administer naloxone and distributing it in affected areas is no guarantee that these users will have it with them when needed. It is also important for both drug users and non-using family members to discuss and plan for preventing and treating overdoses," Latkin says.

His group's follow-on projects are now aimed in part at those issues of availability and witnesses' willingness to use it. "Clearly a lot more needs to be done to resolve this crisis," he says. "In addition to addressing causes of opioid abuse, we need to reduce stigma and increase access to effective drug treatments."

"The relationship between drug use settings, roles in the drug economy, and witnessing a overdose in Baltimore, Maryland" was written by Carl A. Latkin, Catie Edwards, Melissa A. Davey-Rothwell, Cui Yang, and Karin E. Tobin.

Explore further: Let's talk about Rx use—recognizing and reversing an overdose

Related Stories

Let's talk about Rx use—recognizing and reversing an overdose

March 23, 2018
According to the National Institute on Drug Abuse, the misuse of and addiction to opioids is a serious national crisis, with more than 115 Americans dying from opioid overdose every day. Knowing how to prevent and recognize ...

Opioid overdoses in ERs up 30 percent as crisis worsens

March 6, 2018
Emergency rooms saw a big jump in overdoses from opioids last year—the latest evidence the nation's drug crisis is getting worse.

Overdose prevention and naloxone rescue among family members of people who use opioids

April 29, 2017
Family members are often the ones who administer naloxone during an opioid overdose and should be considered as part of the larger response to help curb fatal overdoses. These findings, published online in Drug and Alcohol ...

Opioid abuse leads to heroin use and a hepatitis C epidemic, researcher says

February 22, 2018
Heroin is worse than other drugs because people inject it much sooner, potentially resulting in increased risk of injection-related epidemics such as hepatitis C and HIV, a Keck School of Medicine of USC study shows.

Fatal opioid overdoses on the rise in Canada

February 1, 2018
Fatal opioid overdoses jumped in Canada last year, especially in British Columbia, where the potent sedative fentanyl was detected in eight of 10 overdose deaths, according to preliminary figures released Wednesday.

Recommended for you

New study finds concurrent use of prescription drugs and dietary supplements could pose health risks

September 25, 2018
A new University of Hertfordshire study found that using certain over-the-counter herbal medicines and dietary supplements alongside prescription drugs could pose serious health risks, especially amongst older adults.

Drug overdose epidemic has been growing exponentially for decades

September 20, 2018
Death rates from drug overdoses in the U.S. have been on an exponential growth curve that began at least 15 years before the mid-1990s surge in opioid prescribing, suggesting that overdose death rates may continue along this ...

Anti-cancer drugs may hold key to overcoming antimalarial drug resistance

September 20, 2018
Scientists have found a way to boost the efficacy of the world's most powerful antimalarial drug with the help of chemotherapy medicines, according to new research published in the journal Nature Communications.

Probiotic use may reduce antibiotic prescriptions, researchers say

September 14, 2018
Use of probiotics is linked to reduced need for antibiotic treatment in infants and children, according to a review of studies that probed the benefits of probiotics, say researchers in the U.S., England and the Netherlands.

Recalled blood pressure drugs not linked to increased short term cancer risk

September 12, 2018
Products containing the withdrawn blood pressure drug valsartan are not associated with a markedly increased short term risk of cancer, finds an expedited analysis published by The BMJ today.

Sugar pills relieve pain for chronic pain patients

September 12, 2018
Someday doctors may prescribe sugar pills for certain chronic pain patients based on their brain anatomy and psychology. And the pills will reduce their pain as effectively as any powerful drug on the market, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.